Toshiba Releases Automotive Photorelay with Output Withstand Voltage of 900V

– New device is suitable for 400V automotive battery systems – KAWASAKI, Japan–(BUSINESS WIRE)–Toshiba Electronic Devices…

Wordsmith Appoints Lucy Tyrrell as General Counsel Amidst Rapid Growth and Expansion

Wordsmith AI has hired in-house legal superstar Lucy Tyrrell as it continues to expand, following overwhelming…

Best’s Market Segment Report: Adoption of New Industry Accounting Standard Forces Change in AM Best’s Annual Ranking of Top Reinsurers

OLDWICK, N.J.–(BUSINESS WIRE)–#insurance–The implementation of IFRS 17 accounting standards in the insurance industry has forced a…

Budapest to Be Enchanted by K-Culture with 2024 MOKKOJI KOREA

2024 MOKKOJI KOREA to Bring Korean Cultural Experience to Budapest in October SEOUL, South Korea–(BUSINESS WIRE)–#2024MOKKOJI–Budapest…

Lukas Podolski’s Kebab Franchise to Roll Out Up To 2,400 Autonomous Food Robots From Circus Group

Circus wins Mangal Kebab and Lukas Podolski for the targeted deployment of 2,400 autonomous food robots…

ChargePoint and Daimler Buses partner to enable seamless integration of vehicle telematics solutions

AMSTERDAM–(BUSINESS WIRE)–ChargePoint (NYSE: CHPT), a leading provider of networked charging solutions for electric vehicles (EVs), has…

Aviator LLC Wins $330 Million Trademark and Copyright Claim against Gaming Operators Spribe OÜ and Adjarabet

TBILISI, Georgia–(BUSINESS WIRE)–On August 20, the Court of First Instance in the country of Georgia ruled…

Elliptic Labs Launching on vivo’s iQOO Z9s and iQOO Z9s Pro Smartphones

OSLO, Norway–(BUSINESS WIRE)–#AIVirtualProximitySensor—Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in…

SymphonyAI Connected Retail Portfolio Helps Drive ROSSMANN Group Expansion into Switzerland

Strong brand presence and SymphonyAI AI-based store and space planning position ROSSMANN for successful new market…

GI Innovation Announces New Clinical Trial Collaboration and Supply Agreement to Evaluate GI-102 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Immunotherapy-Resistant Liver Cancer, Melanoma, and Renal Cell Carcinoma

Phase 2 Clinical Trial of GI-102 in Combination with KEYTRUDA for Immunotherapy Resistant Liver Cancer, Melanoma,…